WO2008078424A1 - ベンゾキサゾール誘導体 - Google Patents
ベンゾキサゾール誘導体 Download PDFInfo
- Publication number
- WO2008078424A1 WO2008078424A1 PCT/JP2007/063350 JP2007063350W WO2008078424A1 WO 2008078424 A1 WO2008078424 A1 WO 2008078424A1 JP 2007063350 W JP2007063350 W JP 2007063350W WO 2008078424 A1 WO2008078424 A1 WO 2008078424A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- benzoxazole derivatives
- conformation disease
- composition
- conformation
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0465—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Abstract
コンフォーメーション病の早期診断に有用なベンゾキサゾール誘導体又はその薬学的に許容される塩もしくは溶媒和物、それを含むコンフォーメーション病診断用組成物及びキット、ならびにコンフォーメーション病治療及び/又は予防用医薬組成物などが本発明により提供される。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008550970A JP5190893B2 (ja) | 2006-12-25 | 2007-07-04 | ベンゾキサゾール誘導体 |
EP07768120A EP2103611A4 (en) | 2006-12-25 | 2007-07-04 | benzoxazole |
US12/520,752 US7910579B2 (en) | 2006-12-25 | 2007-07-04 | Benzoxazole derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/325804 WO2007074786A1 (ja) | 2005-12-26 | 2006-12-25 | コンフォーメーション病診断プローブ |
JPPCT/JP2006/325804 | 2006-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008078424A1 true WO2008078424A1 (ja) | 2008-07-03 |
Family
ID=39562218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/063350 WO2008078424A1 (ja) | 2006-12-25 | 2007-07-04 | ベンゾキサゾール誘導体 |
Country Status (3)
Country | Link |
---|---|
US (1) | US7910579B2 (ja) |
EP (1) | EP2103611A4 (ja) |
WO (1) | WO2008078424A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5422782B1 (ja) * | 2012-12-21 | 2014-02-19 | 独立行政法人放射線医学総合研究所 | 脳内に蓄積したタウタンパク質をイメージングするための新規化合物 |
WO2019054427A1 (ja) | 2017-09-14 | 2019-03-21 | 第一三共株式会社 | 環状構造を有する化合物 |
JP2019123675A (ja) * | 2018-01-12 | 2019-07-25 | 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. | 放射性核種標識化合物及びこれを含有するイメージング剤 |
US11291732B1 (en) | 2019-11-13 | 2022-04-05 | Aprinoia Therapeutics Limited | Compounds for degrading α-synuclein aggregates and uses thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013170858A1 (en) | 2012-05-16 | 2013-11-21 | Coloplast A/S | Novel polymeric photoinitiators and photoinitiator monomers |
CN102936228B (zh) * | 2012-11-08 | 2015-03-11 | 江苏省原子医学研究所 | 6-(2-氟乙氧基)-2-甲基苯并噁唑的制备方法 |
US8951258B2 (en) | 2013-03-01 | 2015-02-10 | Warsaw Orthopedic, Inc. | Spinal correction system and method |
US10736672B2 (en) | 2017-05-25 | 2020-08-11 | Warsaw Orthopedic, Inc. | Spinal implant system and method |
GB201712567D0 (en) | 2017-08-04 | 2017-09-20 | Karin & Sten Mortstedt Cbd Solutions Ab | Selective ligands for tau aggregates |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000080082A (ja) | 1998-09-02 | 2000-03-21 | Kuraray Co Ltd | 5−ハロゲノ−2−置換ピリジンの製造方法 |
JP2001076075A (ja) | 1999-09-06 | 2001-03-23 | Toshiba Corp | 賛否投票集計システム |
WO2003018070A1 (en) * | 2001-08-27 | 2003-03-06 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
WO2003106439A1 (ja) * | 2002-06-12 | 2003-12-24 | 株式会社ビーエフ研究所 | アミロイド蓄積性疾患の画像診断プローブ化合物、老人斑/びまん性老人斑染色用化合物、ならびにアミロイド蓄積性疾患の治療薬 |
WO2004035522A1 (ja) | 2002-08-30 | 2004-04-29 | Bf Research Institute, Inc. | プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤 |
WO2005016888A1 (ja) * | 2003-08-13 | 2005-02-24 | Bf Research Institute, Inc. | アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤 |
US9605918B1 (en) | 2015-11-16 | 2017-03-28 | Pro Mag Mfg., Inc. | Rifle magazine with release lever actuator |
US9807889B2 (en) | 2012-07-30 | 2017-10-31 | Osaka University | Method of mounting electronic component to circuit board |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06194780A (ja) * | 1992-12-24 | 1994-07-15 | Konica Corp | ハロゲン化銀写真乳剤 |
US6168776B1 (en) | 1994-07-19 | 2001-01-02 | University Of Pittsburgh | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
HUP9900426A3 (en) | 1995-05-01 | 2001-12-28 | Univ Pittsburgh Pittsburgh | Amyloid binding azoderivatives, preparation thereof and use of these compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
US6001331A (en) | 1996-01-24 | 1999-12-14 | Warner-Lambert Company | Method of imaging amyloid deposits |
JP2000344685A (ja) | 1999-03-26 | 2000-12-12 | Bf Kenkyusho:Kk | アズールa類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物 |
JP2000344684A (ja) | 1999-03-26 | 2000-12-12 | Bf Kenkyusho:Kk | ピロニンb類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物 |
US20030138374A1 (en) * | 2000-03-22 | 2003-07-24 | Yukitsuda Kudo | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same |
AU2001244549A1 (en) | 2000-03-22 | 2001-10-03 | Bf Research Institute, Inc. | Azure a analogues useful as probes in the diagnostic imaging for diseases due toaccumulation of amyloid and compositions for diagnostic imaging containing the analogues |
JP2002275099A (ja) | 2001-03-16 | 2002-09-25 | Bf Kenkyusho:Kk | ベンゾシアゾリン環またはベンゾオキサゾリン環を含む化合物による、アミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物 |
CN1513175A (zh) * | 2001-03-28 | 2004-07-14 | 拜尔公司 | 在信息层中包含作为吸光化合物的部花青染料的光学数据载体 |
CN1659640A (zh) | 2001-03-28 | 2005-08-24 | 拜尔公司 | 在信息层中含有作为光吸收化合物的染料的光数据载体 |
JP2004067659A (ja) | 2002-06-12 | 2004-03-04 | Bf Kenkyusho:Kk | タウ蛋白蓄積性疾患の診断プローブとしてのベンゾイミダゾール環含有化合物 |
WO2004054978A1 (ja) * | 2002-12-16 | 2004-07-01 | Bf Research Institute, Inc. | タウ蛋白蓄積性疾患の診断プローブとしてのキノリン誘導体 |
WO2005016384A1 (ja) * | 2003-08-13 | 2005-02-24 | Bf Research Institute, Inc. | アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤 |
EP1967517A4 (en) | 2005-12-26 | 2012-04-18 | Univ Tohoku | DIAGNOSTIC PROBE OF CONFORMATIONAL DISEASE |
-
2007
- 2007-07-04 US US12/520,752 patent/US7910579B2/en not_active Expired - Fee Related
- 2007-07-04 WO PCT/JP2007/063350 patent/WO2008078424A1/ja active Application Filing
- 2007-07-04 EP EP07768120A patent/EP2103611A4/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000080082A (ja) | 1998-09-02 | 2000-03-21 | Kuraray Co Ltd | 5−ハロゲノ−2−置換ピリジンの製造方法 |
JP2001076075A (ja) | 1999-09-06 | 2001-03-23 | Toshiba Corp | 賛否投票集計システム |
WO2003018070A1 (en) * | 2001-08-27 | 2003-03-06 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
WO2003106439A1 (ja) * | 2002-06-12 | 2003-12-24 | 株式会社ビーエフ研究所 | アミロイド蓄積性疾患の画像診断プローブ化合物、老人斑/びまん性老人斑染色用化合物、ならびにアミロイド蓄積性疾患の治療薬 |
WO2004035522A1 (ja) | 2002-08-30 | 2004-04-29 | Bf Research Institute, Inc. | プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤 |
WO2005016888A1 (ja) * | 2003-08-13 | 2005-02-24 | Bf Research Institute, Inc. | アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤 |
US9807889B2 (en) | 2012-07-30 | 2017-10-31 | Osaka University | Method of mounting electronic component to circuit board |
US9605918B1 (en) | 2015-11-16 | 2017-03-28 | Pro Mag Mfg., Inc. | Rifle magazine with release lever actuator |
Non-Patent Citations (20)
Title |
---|
AGDEPPA ET AL., JOURNAL OF NEUROSCIENCE, vol. 21, 2001, pages RC189 |
BRAAK H.; BRAAK E., AC.TA NEUROPATHOL., vol. 82, 1991, pages 239 - 259 |
CAI ET AL., JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, 2004, pages 2208 - 2218 |
CHANG ET AL., NUCLEAR MEDICINE AND BIOLOGY, vol. 33, 2006, pages 811 - 820 |
ISHIGURO ET AL., NEUROSC-YLETT., vol. 270, 1999, pages 81 - 84 |
ITOH ET AL., ANN. NEUROL., vol. 50, 2001, pages 150 - 156 |
KUDO ET AL., JOURNAL OF NUCLEAR MEDICINE, vol. 48, 2007, pages 553 - 561 |
KUNG ET AL., BRAIN RESEARCH, vol. 956, 2002, pages 202 |
LE VINE, PROTEIN SCIENCE, vol. 2, 1993, pages 404 - 410 |
PUCHTLER ET AL., JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY, vol. 10, 1962, pages 35 |
PUCHTLER ET AL., JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY, vol. 77, 1983, pages 431 |
See also references of EP2103611A4 |
STEPHENSON ET AL., BIOCONJUGATE CHEMISTRY, vol. 18, 2007 |
SYNTHESIS, vol. 1, 1984, pages 1 - 28 |
T. W. GREEN: "Protective Groups in Organic Synthesis", 1991, JOHN WILEY & SONS |
T. W. GREEN: "Synthesis", 1991, JOHN WILEY & SONS |
TIPRE ET AL., JOURNAL OF NUCLEAR MEDICINE, vol. 47, 2006, pages 345 - 353 |
WISCHIK ET AL.: "Neurobiology of Alzheimer's Disease", 2001, OXFORD UNIVERSITY PRESS, pages: 103 - 206 |
YANKNER ET AL., SCIENCE, vol. 245, 1989, pages 417 - 420 |
ZHANG ET AL., JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, 2005, pages 5980 - 5988 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5422782B1 (ja) * | 2012-12-21 | 2014-02-19 | 独立行政法人放射線医学総合研究所 | 脳内に蓄積したタウタンパク質をイメージングするための新規化合物 |
WO2014097474A1 (ja) * | 2012-12-21 | 2014-06-26 | 独立行政法人放射線医学総合研究所 | 脳内に蓄積したタウタンパク質をイメージングするための新規化合物 |
US11667628B2 (en) | 2012-12-21 | 2023-06-06 | National Institutes For Quantum And Radiological Science And Technology | Compounds for imaging tau proteins that accumulate in brain |
WO2019054427A1 (ja) | 2017-09-14 | 2019-03-21 | 第一三共株式会社 | 環状構造を有する化合物 |
JP2019123675A (ja) * | 2018-01-12 | 2019-07-25 | 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. | 放射性核種標識化合物及びこれを含有するイメージング剤 |
CN111556868A (zh) * | 2018-01-12 | 2020-08-18 | 上海富吉医疗器械有限公司 | 放射性核素标记化合物和含有该化合物的显影剂 |
KR20200109335A (ko) | 2018-01-12 | 2020-09-22 | 상하이 차트웰 메디컬 인스트루먼트 컴퍼니 리미티드 | 방사성 핵종 표지 화합물 및 이것을 함유하는 이미징제 |
CN111556868B (zh) * | 2018-01-12 | 2023-03-28 | 上海富吉医疗科技有限公司 | 放射性核素标记化合物和含有该化合物的显影剂 |
US11291732B1 (en) | 2019-11-13 | 2022-04-05 | Aprinoia Therapeutics Limited | Compounds for degrading α-synuclein aggregates and uses thereof |
US11642413B2 (en) | 2019-11-13 | 2023-05-09 | Aprinoia Therapeutics Limited | Compounds for degrading Tau protein aggregates and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
US20100021385A1 (en) | 2010-01-28 |
EP2103611A1 (en) | 2009-09-23 |
US7910579B2 (en) | 2011-03-22 |
EP2103611A4 (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008078424A1 (ja) | ベンゾキサゾール誘導体 | |
WO2006098918A3 (en) | Substituted gamma lactams as therapeutic agents | |
WO2007149030A8 (en) | Novel heteroaryl substituted benzoxazoles | |
TW200736252A (en) | Novel heteroaryl substituted benzothiazoles | |
AU2005313582A8 (en) | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease | |
GEP20094723B (en) | Tetraazabenzo [e] azulene derivatives and analogs thereof | |
BRPI0518993A2 (pt) | composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto | |
NO20084853L (no) | Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni | |
WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
EP1933883A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS OF IGA- AND IGM-MEDICINED KIDNEY DISEASES | |
WO2009066152A3 (en) | Haloallylamine inhibitors of ssao/vap-1 and uses therefor | |
EP2069768A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE-2 DIABETES | |
WO2007130075A8 (en) | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors | |
IL192150A (en) | Use of 2-amino-2- [4- (3-benzyloxyphenylthio) -2-chlorophyll} ethyl-1,3-propanadiol, or its acceptable medical salt or hydrate, for the preparation or treatment of inflammatory bowel disease | |
WO2008091540A3 (en) | 23-substituted bile acids as tgr5 modulators and methods of use thereof | |
WO2007046868A3 (en) | Thiazolidine derivatives and their uses as therapeutic agents | |
BRPI0607545A2 (pt) | composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
ZA200605631B (en) | Directly compressible pharmaceutical composition for the oral administration of CCI-779 | |
WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
WO2007046867A3 (en) | Piperidine derivatives and their uses as therapeutic agents | |
HK1134923A1 (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
WO2008053446A3 (en) | Benzoxazepine compounds, their preparation and use | |
RS20050470A (en) | Solid drug for oral use | |
WO2008006795A3 (en) | Indole compounds | |
EP1784173A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC BONE DISEASES CONTAINING ALPHA-ARYLMETHOXYACRYLATE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07768120 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12520752 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008550970 Country of ref document: JP Ref document number: 2007768120 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |